Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Abbott issues US device correction for some glucose monitors over faulty readings risk - 2Changes to CDC website spark debate over autism and vaccine misinformation
- 3Russian military plane crashes in annexed Crimea, killing 29 people on board
- 4A Timeline of Rising Antisemitism in Australia
- 5Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- Vote In favor of Your Number one Game Control center
- 7 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Far reaching Guide
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- Vote in favor of your Favored Kind of Scarf
- The gay hockey show no one saw coming — and everyone is suddenly obsessed with
- Figure out How to Get the Most Familiar Drive for Seniors in SUVs
- A rare whale is having an encouraging season for births. Scientists warn it might still go extinct
- Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
- Instructions to Keep up with Your Traded Teeth for Life span
